The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 16, 2022
Filed:
Dec. 13, 2017
Applicant:
Novozymes A/s, Copenhagen N, DK;
Inventors:
Peter Nordkild, Gentofte, DK;
Søren Kjærulff, Holte, DK;
Assignee:
NOVOZYMES A/S, Bagsvaer, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61P 11/06 (2006.01); A61K 9/00 (2006.01); A61K 38/38 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1729 (2013.01); A61K 9/007 (2013.01); A61K 9/0053 (2013.01); A61K 38/38 (2013.01); A61K 45/06 (2013.01); A61P 11/06 (2018.01);
Abstract
The present invention relates to methods for treatment or prevention of asthma, mild intermittent asthma, mild persistent asthma, moderate persistent asthma, severe persistent asthma, eosinophilic asthma, neutrophilic asthma, steroid refractory asthma, status asthmaticus, pneumonia, bronchiectasis, COPD, sarcoidosis, and lung cancer based on reducing airway hyper responsiveness, increasing pulmonary compliance, reducing lung inflammation, reducing inflammatory cell count in bronchoalveolar fluid and reducing cytokine production by administration of a mammalian α- and/or β-defensin.